Longitudinal radiological follow-up of individual level non-ischemic cerebral enhancing lesions following endovascular aneurysm treatment

医学 血管内治疗 动脉瘤 放射科 放射性武器 外科
作者
Zakaria Guetarni,R Bernard,Grégoire Boulouis,Marc‐Antoine Labeyrie,Alessandra Biondi,Stéphane Velasco,Guillaume Saliou,Bruno Bartolini,Benjamin Daumas-Duport,Romain Bourcier,Kévin Janot,Denis Herbreteau,Caterina Michelozzi,Kévin Premat,Hocine Redjem,Simon Escalard,Nicolas Bricout,Pierre Thouant,Charles Artéaga,Laurent Pierot
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:16 (8): 838-845 被引量:5
标识
DOI:10.1136/jnis-2023-020060
摘要

Background Non-ischemic cerebral enhancing (NICE) lesions following aneurysm endovascular therapy are exceptionally rare, with unknown longitudinal evolution. Objective To evaluate the radiological behavior of individual NICE lesions over time. Methods Patients included in a retrospective national multicentric inception cohort were analyzed. NICE lesions were defined, using MRI, as delayed onset punctate, nodular, or annular foci enhancements with peri-lesion edema, distributed in the vascular territory of the aneurysm treatment, with no other confounding disease. Lesion burden and the longitudinal behavior of individual lesions were assessed. Results Twenty-two patients were included, with a median initial lesion burden of 36 (IQR 17–54) on the first MRI scan. Of the 22 patients with at least one follow-up MRI scan, 16 (73%) had new lesions occurring mainly within the first 200 weeks after the date of the procedure. The median number of new lesions per MRI was 6 (IQR 2–16). Among the same 22 patients, 7 (32%) had recurrent lesions. The median persistent enhancement of a NICE lesion was 13 weeks (IQR 6–30). No factor was predictive of early regression of enhancement activity with lesion regression kinetics mainly being patient-dependent. Conclusions The behavior of individual NICE lesions was found to be highly variable with an overall patient-dependent regression velocity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
自信号厂完成签到 ,获得积分0
刚刚
完美世界应助小草三心采纳,获得10
1秒前
Sicecream完成签到,获得积分10
1秒前
淼淼发布了新的文献求助10
2秒前
2秒前
任慧娟发布了新的文献求助10
2秒前
郭擎擎完成签到,获得积分10
3秒前
FashionBoy应助高宇采纳,获得10
4秒前
Mrsummer发布了新的文献求助10
4秒前
小郭发布了新的文献求助10
5秒前
拓跋箴发布了新的文献求助10
5秒前
6秒前
淡淡的航空完成签到,获得积分10
6秒前
sqz完成签到,获得积分10
6秒前
梦城完成签到,获得积分10
7秒前
852应助科研通管家采纳,获得10
7秒前
7秒前
慕青应助Nisaix采纳,获得10
7秒前
华仔应助科研通管家采纳,获得30
7秒前
7秒前
7秒前
CodeCraft应助科研通管家采纳,获得10
7秒前
思源应助科研通管家采纳,获得10
8秒前
wsyiming完成签到,获得积分10
8秒前
英姑应助科研通管家采纳,获得10
8秒前
香蕉觅云应助科研通管家采纳,获得10
8秒前
我是老大应助科研通管家采纳,获得10
8秒前
8秒前
8秒前
我喜欢高浩洋应助niu采纳,获得10
8秒前
9秒前
9秒前
11秒前
11秒前
脑洞疼应助快乐的远航采纳,获得10
11秒前
小冰完成签到,获得积分10
11秒前
科研通AI6.3应助张巨锋采纳,获得10
11秒前
万能图书馆应助飞鱼采纳,获得10
11秒前
情怀应助生动的翠容采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
Research Methods for Business: A Skill Building Approach, 9th Edition 500
Social Work and Social Welfare: An Invitation(7th Edition) 410
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6053426
求助须知:如何正确求助?哪些是违规求助? 7872390
关于积分的说明 16278311
捐赠科研通 5198785
什么是DOI,文献DOI怎么找? 2781636
邀请新用户注册赠送积分活动 1764556
关于科研通互助平台的介绍 1646184